Tagged: colorado Toggle Comment Threads | Keyboard Shortcuts

  • ShereeKrider 12:19 am on December 3, 2015 Permalink | Reply
    Tags: Australia, , , colorado, Illinois, , Leafly, , Virginia,   

    Virginia’s Cannabis Arrest Rates Skyrocket: The Leafly Legalization Roundup 


    U.S. Cannabis Updates

    CALIFORNIA

    The Newport Beach City Council approved an ordinance banning dispensaries and delivery services in the area amid protests from the community. This ordinance prohibits the cultivation, processing, distribution, and delivery of medical marijuana in Newport Beach, and comes as a response to the Medical Marijuana Regulation and Safety Act, which was signed into law by Governor Jerry Brown on October 9th.

    Although the law will not go into effect until January 1st, 2016, one of the stipulations of the law is that local jurisdictions must take action now if they want to impose bans or moratoriums on medical marijuana; otherwise, the state will become the sole regulator for medical cannabis in the state of California.

    COLORADO

    A troubling report from CNN confirmed that high levels of banned pesticides have been turning up in medical and recreational marijuana products that are sold to the general public. Various samples tested positive for a neurotoxin known as imidacloprid, which was banned for use on marijuana crops. Even brief exposure to the chemical can have serious side effects, such as irritation, dizziness, breathlessness, confusion, and vomiting. The tests found that products contained more than 100 times the legal amount and resulted in 2,362 products being pulled from the shelves, having been deemed unfit for public consumption.

    The report comes directly after an executive order from Governor John Hickenlooper was issued urging local agencies to destroy products that contain high levels of pesticides and contaminants.

    ILLINOIS

    Cultivators in Southern Illinois, Murphysboro, and Anna have been given the green light to begin cultivating strains for Illinois’ medical cannabis program. Two companies, Ieso and Wellness Group Pharms, have begun the process of cultivation, although it will be several months before any product will hit dispensary shelves. Ieso will be using a 23,000 square-foot greenhouse at the cultivation center in Southern Illinois Airport, and Wellness Group Pharms has a 27,000 square-foot facility in Anna that has started production.

    Tom Jennings, co-manager of Ieso, said that they’re starting with a staff of 14, hiring for another six positions, and will likely expand in the future (check out Ieso’s careers page if you’re interested in applying for an open position). Paul Montes, managing partner of Wellness Group Pharms, said that they have a team of eight and will be hiring more employees as they grow their team and security for the facility. If you’d like to join the Wellness Group "Phamily," you can download their job application.

    VIRGINIA

    In the ultra-conservative state of Virginia, a report released by the Drug Policy Alliance highlights a disconcerting pattern that has emerged in the state’s arrest records for marijuana. Despite a nationwide drop of 6.5 percent in arrests for marijuana possession between 2003 and 2014, arrests in Virginia for marijuana possession skyrocketed by 76 percent during the same time period. Not only that, but there was a clear racial disparity in marijuana arrests – the state saw an increase of 106 percent in arrests of black people between 2003 and 2014, accounting for 47 percent of Virginia’s arrests even though its population is only 20 percent black.

    In the meantime, just across the river in Washington, D.C., as of November 6th, the District’s marijuana arrests dropped a whopping 99.2 percent. In an area once rife with arrests for marijuana possession (and once home to a clear racial disparity in arrests as well), so far this year there have been a total of exactly seven people arrested for marijuana in D.C.

    WISCONSIN

    A bill is under consideration by the Wisconsin legislature that would legalize the medicinal use of cannabidiol oil for those with severe seizure disorders who qualify. Senate Bill 221 would amend the Wisconsin Constitution to distinguish between cannabidiol (CBD) and tetrahydrocannabinol (THC), so as to allow physicians to recommend the use of the oil to be dispensed by an approved pharmacy or doctor.

    Families with children who suffer from seizure disorders tearfully petitioned legislators to pass the bill at a hearing for the bill last week, but unfortunately the Wisconsin Medical Society has already come out against the legislation, citing a lack of research.

    International Cannabis Updates

    AUSTRALIA

    A cannabis crop bigger than the Sydney Football Stadium was discovered on a secluded walking trail in New South Wales at the Bundjalung National Park. More than 8,500 plants, worth an estimated $6.2 million, were surreptitiously planted in a patch of juvenile plants surrounded by a fence 150 meters by 50 meters (164 yards by 54.6 yards). The entire crop was seized by the NSW’s Cannabis Eradication Program and incinerated in a massive bonfire, the likes of which we can only imagine.

    ISRAEL

    A recent poll showed that the vast majority of Israeli college students believe that Israeli drug policy should differentiate between cannabis and much harder drugs like heroin and cocaine. The National Union of Israeli Students found that 89 percent of students would like to see a change in drug policy to reflect the difference between the types of drugs. Additionally, 43 percent said that cannabis should be legalized and sold under government regulation, while 2 percent favored a free-for-all system in which anyone could buy or sell drugs. The percentage of respondents who favored total prohibition on cannabis also dropped from 14 percent last year to 11 percent in 2015.

    Catch up on last week’s roundup, or check out our other legalization news articles!

    CONTINUE READING…

     
  • ShereeKrider 9:12 pm on June 22, 2015 Permalink | Reply
    Tags: colorado, Dish Network, , , random drug testing,   

    The Supreme Court of Colorado ruled unanimously last week that Dish Network acted lawfully when it fired a quadriplegic employee who used medicinal marijuana legally to control leg spasms and while he was not at work. 


     

     

    pee-cup

     

    The Supreme Court of Colorado ruled unanimously last week that Dish Network acted lawfully when it fired a quadriplegic employee who used medicinal marijuana legally to control leg spasms and while he was not at work. The employee, Brandon Coats, was fired in 2010 when he failed a random drug test.

    Needless to say, this was not a popular decision among marijuana legalization activists. In his appeal, Coats claimed that Colorado labor laws legitimized his use of marijuana, making his firing illegal under those same laws. The court’s ruling held that the term “lawful activity” must be considered in both a federal and a state legal context. Because marijuana use remains illegal under federal law and marijuana itself is classified as a Schedule 1 drug, the fact that both the Congress and the Obama administration’s Justice Department have signaled that enforcement will be both lightly funded and lightly enforced does not supersede the law. Under federal law, marijuana is a dangerous and illegal drug and that is the end of the story, regardless of the feds’ “wink-wink-nod-nod” approach.

    At the Brookings Institution’s Fixgov blog, managing editor John Hudak noted:

    Federal efforts have limited funding for the use of enforcing medical marijuana laws (Congress) or use prosecutorial discretion to limit the enforcement of marijuana laws (Department of Justice). However, those moves do not resolve the serious disconnects in the law that extend far beyond a medical marijuana patient fearing prosecution. Inconsistencies between state and federal marijuana laws extend to issues of employment, housing, banking, property rights, and a variety of other areas

    We have noted before that the lack of a federal law — which only Congress can pass — raises any number of obstacles for companies in the marijuana industry. Dispensaries and growers cannot find bankers willing to take their cash deposits, and even a state government is having difficulty finding a willing bank. With almost half the states having approved the use of medical marijuana, perhaps it is time for Congress to fix a system that is truly broken.

    ALSO READ: The 10 Largest Marijuana Companies

    Read more: Congress Deserves Blame for Colorado Ruling Against Medical Marijuana – 24/7 Wall St. http://247wallst.com/consumer-products/2015/06/22/congress-deserves-blame-for-colorado-ruling-against-medical-marijuana/#ixzz3dpMMqgIa
    Follow us: @247wallst on Twitter | 247wallst on Facebook

     
  • ShereeKrider 2:03 am on May 1, 2012 Permalink | Reply
    Tags: , colorado, Melamede, science   

    Cannabis Science Makes Medical Moves at The 7th Patients Out of Time medical cannabis conference in Tucson at the Loews Ventana Canyon Resort 


    press release April 30, 2012, 8:44 a.m. EDT

    COLORADO SPRINGS, Colo., Apr 30, 2012 (BUSINESS WIRE) — Cannabis Science, Inc. a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, was honored to be the Sponsor and an Exhibitor at the 7th national Patients Out of Time, medical cannabis conference in Tucson, Arizona. The conference was attended by patients, doctors, nurses, pharmacists, professors, supporters, and entrepreneurs of the medical cannabis industry. Our own Dr. Melamede presented patient’s results that we have documented at http://www.cannabisscience.com .

    The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Patients Out of Time is the only accredited CME program to educate medical professionals about cannabis as a medicine. There were over 25 world-renowned doctors and scientists sharing and presenting the latest research advances as the complexity of the endo-cannabinoid system continues to unfold. Please see the previous news release from April 17, 2012 at http://finance.yahoo.com/news/dr-robert-melamede-scheduled-speak-182800051.html

    Speakers at the conference focused on the science and medicine of cannabinoids. Cannabis Science was overwhelmed, with great feedback by various representatives in the medical community. Prominent speakers included Dr. Robert Melamede, CEO and president of Cannabis Science; Dr. William Courtney of Cannabis Science’s scientific advisory board, and Dr. Andrew Weil, best selling author, speaker, and Integrative Medicine thought-leader. Talks covered specific ailments such as PTSD, cancer, and even drug addiction; research on cannabinoid science and medical applications, and law. Dr. Robert Melamede shared pictures show on our website. Cannabis Science helps cancer patients make informed choices regarding treatments. He also spoke as to the holistic nature by which the endocannabinoid system regulated homeostasis in all vertebrates from conception till death and therefore, why cannabis-based medicines are different from all others in their ability to help with so many illnesses.

    Cannabis Science demonstrated a pre-release our multi-tiered, digital educational platform to be announced in more detail later this week. Our novel platform will help to meet the ever-expanding interest in cannabis that is coming from the medical communities as the almost miraculous medical benefits of cannabis emerge from the states that support medical marijuana. Our new educational platform (see below) will bring in revenues as we fill the emerging educational need of the medical community. Realistic cannabis education programs are not currently available in the professional schools that need them to end the disconnect between medical cannabis patients an their physicians.

    At the conference the Cannabis Science booth collected data from attendees interested in Cannabis Science Stock and there was a lot of interest in our new branding platform.. Attendees were given PR Packets with CBIS information on cancer, Alzheimer’s, PTSD, aging, and heart disease. CBIS had attendees fill out a questionnaire to enter into a drawing for an iPad 3, a symbolic prize since Cannabis Science will launce our new digital education platform for Physicians, on the Apple iPad platform. Our congratulations to our conference iPad winner.

    Andrew Pitsicalis, the Branding and Licensing Director for Cannabis Science, revealed the new digital platform and demonstrated the technology at the CBIS booth. Pitsicalis coordinated many interviews with Cannabis Planet TV, Arizona Clinics TV, The Phoenix Arizona Times, and local news and media. As a result, we had the honor to meet with a brain cancer survivor of an extremely dangerous surgery. In December of last year, he had a second operation to try to reduce the large mass in his brain. With stage 4 cancer, he came to Cannabis Science to help us create awareness for other cancer patients worldwide so that they too might understand there is hope with cannabis. The patient had not been a previous cannabis user, and was amazed at the impact the plant had on him. In fact, it prevented him from taking his own life, when he was no longer able to cope with having multiple grand mal seizures daily. The patients close friend begged him to smoke cannabis. When he did, he stopped having seizures. He told us he drove 7 hours to meet Dr. Robert Melamede because he was watching his videos our website and YouTube and found hope. The patient wanted to go to the conference to meet him and other doctors and scientists attending the conference.

    The Patients Out of Time charity benefit dinner included entertainment by Greta Gaines from her upcoming album "Grassy Girl;" a live and silent auction, and a guest appearance by Gigi Ganjay. Greta’s information may be found at http://www.gretagaines.com , http://www.cannibuzz.com , and her reel at http://www.conlincasting.net/Gretareel/Greta_Gaines/Reel.html Greta Gaines is a client of Kaneabis (a Cannabis Science company).

    If you would like to view information that Cannabis Science provided to the attendees of the conference, please visit our website.

    Dr. Robert Melamede stated, "Things have never been better for Cannabis Science and this was confirmed at the conference this past weekend. Not only were we part of an historic event with Patients Out of Time, the amount of consciousness and knowledge gained by everyone attending will shape the medicinal science of the industry going forward. Furthermore, our network of professionals increased substantially as we continue to grow the Cannabis Science business model. Most importantly, this conference was a success because it was about the patients, and we heard dramatic testimonials from them, It was all about doing the right things, with the right people, for the right reasons."

    About Cannabis Science, Inc.

    Cannabis Science, Inc. is at the forefront of pharmaceutical grade medical marijuana research and development. The second formulations will address the needs of patients choosing to use concentrated cannabis extracts to treat their ailments. Eventually, all Americans will have access to a safe and effective FDA approved medicine regardless of which state they live in. To maintain that marijuana is a dangerous, addictive drug with no medical value is scientifically absurd. Cannabis medicines, with no effective lethal dose, are far safer than aspirin, acetaminophen, and most other OTC drugs that kill thousands of Americans every year.

    The Company works with world authorities on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance.

    Forward Looking Statements

    This Press Release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Act of 1934. A statement containing works such as "anticipate," "seek," intend," "believe," "plan," "estimate," "expect," "project," "plan," or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Some or all of the events or results anticipated by these forward-looking statements may not occur. Factors that could cause or contribute to such differences include the future U.S. and global economies, the impact of competition, and the Company’s reliance on existing regulations regarding the use and development of cannabis-based drugs. Cannabis Science, Inc. does not undertake any duty nor does it intend to update the results of these forward-looking statements.

    SOURCE: Cannabis Science, Inc.

            
            Cannabis Science Inc. 
            Dr. Robert J. Melamede 
            President & CEO 
            888-889-0888 
            info@cannabisscience.com 
     
    www.cannabisscience.com            or 
            Robert Kane 
            Vice President of Investor Relations 
            561-234-6929 
            rkane@cannabisscience.com 
     
    www.cannabisscience.com            
    
    
    CONTINUE READING...
     
c
Compose new post
j
Next post/Next comment
k
Previous post/Previous comment
r
Reply
e
Edit
o
Show/Hide comments
t
Go to top
l
Go to login
h
Show/Hide help
shift + esc
Cancel
%d bloggers like this: